Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comprehensive antiphospholipid antibody profiling and unsupervised immune phenotyping in fetal growth restriction.

Frontiers in immunology - 1 Jan 2026

Li Siyin, Shu Xiaofang, Shi Juan, Zou Jinmei, Wang Kai

Abstract excerpt

Background: Non-criteria antiphospholipid antibodies (aPLs) may be associated with adverse obstetric outcomes in patients who do not meet conventional antiphospholipid syndrome (APS) classification criteria. Their clinical relevance in fetal growth restriction (FGR) remains incompletely defined. Methods: This retrospective cohort study included 104 pregnant women with FGR or related adverse obstetric...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Antiphospholipid
Share to Antiphospholipid Syndrome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers

Share to Birth Weight

Share to Fetal Growth Retardation

Share to Gestational Age

Share to Immunophenotyping

Share to Pregnancy Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 42317331
DOI: 10.3389/fimmu.2026.1845168
PMCID: PMC13272371

Genes

FGR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comprehensive antiphospholipid antibody profiling and unsupervised immune phenotyping in fetal growth restriction.PMID 42317331Read ↗

Non-Criteria Obstetric Antiphospholipid Syndrome: Myth or Reality?Semantic proximity Read ↗

Antiphospholipid Antibodies Increase the Risk of Fetal Growth Restriction: A Systematic Meta‐AnalysisSemantic proximity Read ↗

Multimodal immune phenotyping of maternal peripheral blood in normal human pregnancySemantic proximity Read ↗

Profiles of criteria and non-criteria anti-phospholipid autoantibodies are associated with clinical phenotypes of the antiphospholipid syndromeSemantic proximity Read ↗

Integrated Clinical and Molecular Profiling of Fetal Growth Disorders in the First TrimesterSemantic proximity Read ↗

Four clinical and biological phenotypes in antiphospholipid syndrome: a cluster analysis of 174 patients with antinuclear antibody tests.Semantic proximity Read ↗

Clinical Characteristics and Prognosis of Patients With Antiphospholipid Antibodies Based on Cluster Analysis: An 8-Year Cohort StudySemantic proximity Read ↗

Fibronectin 1 is a novel biomarker of obstetric antiphospholipid syndromeSemantic proximity Read ↗

Ultrasound and biochemical predictors of pregnancy outcome at diagnosis of early-onset fetal growth restrictionSemantic proximity Read ↗

Fetal and neonatal alloimmune thrombocytopenia: Current pathophysiological insights and perspectives for future diagnostics and treatmentSemantic proximity Read ↗

Phenotypes in antiphospholipid syndrome: A hierarchical cluster analysis based on two independent databases.Semantic proximity Read ↗

Maternal PlGF and umbilical Dopplers predict pregnancy outcomes at diagnosis of early-onset fetal growth restrictionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.